- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CStone Pharmaceuticals (2616)
Assess today's live CStone Pharmaceuticals (2616) share price, performance and insights using our live Hong Kong: 2616 stock exchange data.
Analyse the historical data and CStone Pharmaceuticals share price performance charts on this page. Our technical summary section provides analysis on CStone share price buy/sell indicators using real-time data (or discuss the CStone (2616) stock price today with other investors in the CStone HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK 2616 share price (ISIN: KYG2588M1006) to enhance your trading decisions with our free investment tools and resources.
What Is the CStone Pharmaceuticals Share Price Today?
The CStone share price today is 5.91.
What Is the Stock Symbol for CStone Pharmaceuticals
The stock symbol (or 'ticker') for CStone Pharmaceuticals is "2616."
What Stock Exchange Does CStone Pharmaceuticals Trade On?
CStone Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is CStone Pharmaceuticals a Good Stock to Buy?
Determining whether CStone Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and CStone Pharmaceuticals share price performance charts on this page. Our technical summary section provides analysis on CStone share price buy/sell indicators using real-time data (or discuss the CStone (2616) stock price today with other investors in the CStone HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK 2616 share price (ISIN: KYG2588M1006) to enhance your trading decisions with our free investment tools and resources.
What Is the CStone Pharmaceuticals Share Price Today?
The CStone share price today is 5.91.
What Is the Stock Symbol for CStone Pharmaceuticals
The stock symbol (or 'ticker') for CStone Pharmaceuticals is "2616."
What Stock Exchange Does CStone Pharmaceuticals Trade On?
CStone Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is CStone Pharmaceuticals a Good Stock to Buy?
Determining whether CStone Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Hong Kong
Currency in HKD
5.91
-0.01(-0.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.82
6.03
52 wk Range
2.03
13.15
2616 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.826.03
52 wk Range
2.0313.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2616 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
14.02
Upside
+137.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
CStone Company Profile
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory natural killer/T cell lymphoma; GAVRETO (pralsetinib), a RET inhibitor to treat patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers, as well as NSCLC and multiple tumors; and AYVAKIT (avapritinib), a KIT/PDGFRA inhibitor for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation, and systematic mastocytosis. Its product pipeline includes Nofazinlimab (CS 1003), a PD-1 antibody to treat patients with hepatocellular carcinoma. The company’s products also comprise CS1002, CS2009, CS2011, CS5007, CS5005, CS5008, CS5005-R, CS5006, and CS5009 for the treatment of solid tumors; CS5001 to treat solid tumors and hematologic malignancies; and CS2013 and CS2015 for the treatment of autoimmune diseases. CStone Pharmaceuticals was incorporated in 2015 and is headquartered in Suzhou, China.
Compare 2616 to Peers and Sector
Metrics to compare | 2616 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2616PeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.4x | −19.6x | −0.5x | |
PEG Ratio | 0.13 | −0.14 | 0.00 | |
Price/Book | 24.4x | 4.2x | 2.6x | |
Price / LTM Sales | 38.0x | 15.8x | 3.3x | |
Upside (Analyst Target) | 120.5% | 55.3% | 46.0% | |
Fair Value Upside | Unlock | −11.8% | 5.4% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.02
(+137.29% Upside)
Earnings
Latest Release
Sep 29, 2025
EPS / Forecast
-0.21 / --
Revenue / Forecast
49.45M / --
FAQ
What Is the CStone (2616) Share Price Today?
The live CStone share price today is 5.91
What Stock Exchange Does CStone (2616) Trade On?
CStone is listed and trades on the Hong Kong Stock Exchange.
What Is the Ticker (Stock Symbol) for CStone?
The stock symbol (also called a 'ticker') for CStone is "2616."
What Is the Current CStone Market Cap?
As of today, CStone market capitalisation is 8.70B.
What Is CStone's (2616) Earnings Per Share (TTM)?
The CStone EPS is currently -0.29 (Trailing Twelve Months).
Is 2616 a Buy or Sell From a Technical Analyst Perspective?
Based on today's CStone moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has CStone Stock Split?
CStone has split 0 times. (See the 2616 stock split history page for full effective split date and price information.)
How Many Employees Does CStone Have?
CStone has 131 employees.
What is the current trading status of CStone (2616)?
As of 18/02/2026, CStone (2616) is trading at a price of 5.91, with a previous close of 5.92. The stock has fluctuated within a day range of 5.82 to 6.03, while its 52-week range spans from 2.03 to 13.15.
What Is CStone (2616) Price Target According to Analysts?
The average 12-month price target for CStone is HKD14.02, with a high estimate of HKD20.74321267 and a low estimate of HKD8.29638009. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +137.29% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.